Maravai LifeSciences Holdings, Inc. MRVI FX Effect on Cash
FX Effect on Cash at other companies
Other financials
Where this comes from
Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Maravai LifeSciences Holdings, Inc.'s fx effect on cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Maravai LifeSciences Holdings, Inc.'s FX effect on cash?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported FX effect on cash of $30K in Q1 2026.
- How has Maravai LifeSciences Holdings, Inc.'s FX effect on cash changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s FX effect on cash decreased by 58.9% year-over-year, from $73K to $30K.
- What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s FX effect on cash?
- Over 3 years (2021 to 2024), Maravai LifeSciences Holdings, Inc.'s FX effect on cash has grown at a -100.0% compound annual growth rate (CAGR), from -$88K to $0.
- What does FX effect on cash mean?
- The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.